HLVX
Price
$1.99
Change
+$0.03 (+1.53%)
Updated
Jun 6, 04:21 PM (EDT)
Capitalization
97.95M
62 days until earnings call
NTLA
Price
$8.12
Change
+$0.53 (+6.99%)
Updated
Jun 6, 04:32 PM (EDT)
Capitalization
784.13M
55 days until earnings call
Interact to see
Advertisement

HLVX vs NTLA

Header iconHLVX vs NTLA Comparison
Open Charts HLVX vs NTLABanner chart's image
HilleVax
Price$1.99
Change+$0.03 (+1.53%)
Volume$300
Capitalization97.95M
Intellia Therapeutics
Price$8.12
Change+$0.53 (+6.99%)
Volume$2.02K
Capitalization784.13M
HLVX vs NTLA Comparison Chart
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. NTLA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a Hold and NTLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (HLVX: $1.96 vs. NTLA: $7.57)
Brand notoriety: HLVX and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 39% vs. NTLA: 100%
Market capitalization -- HLVX: $97.95M vs. NTLA: $784.13M
HLVX [@Biotechnology] is valued at $97.95M. NTLA’s [@Biotechnology] market capitalization is $784.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, HLVX is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • HLVX’s TA Score: 3 bullish, 5 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than HLVX.

Price Growth

HLVX (@Biotechnology) experienced а +5.11% price change this week, while NTLA (@Biotechnology) price change was +1.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

HLVX is expected to report earnings on Aug 07, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($784M) has a higher market cap than HLVX($97.9M). HLVX YTD gains are higher at: -5.556 vs. NTLA (-35.077). HLVX has higher annual earnings (EBITDA): -100.93M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. HLVX (160M). HLVX has less debt than NTLA: HLVX (24M) vs NTLA (119M). NTLA has higher revenues than HLVX: NTLA (45.6M) vs HLVX (0).
HLVXNTLAHLVX / NTLA
Capitalization97.9M784M12%
EBITDA-100.93M-530.8M19%
Gain YTD-5.556-35.07716%
P/E RatioN/AN/A-
Revenue045.6M-
Total Cash160M504M32%
Total Debt24M119M20%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLVXNTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUBGY27.050.26
+0.97%
Publicis Groupe S.A.
HNGKY27.00-0.05
-0.17%
Hongkong Land Holdings Ltd.
DASTF36.61-0.52
-1.40%
Dassault Systemes SA
BUDZ0.03N/A
-9.27%
WEED, Inc.
RECAF0.34-0.08
-19.69%
Reconnaissance Energy Africa Ltd.

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-1.26%
FBIOP - HLVX
82%
Closely correlated
+4.17%
BRIBF - HLVX
55%
Loosely correlated
N/A
PLRX - HLVX
37%
Loosely correlated
-2.71%
NTLA - HLVX
37%
Loosely correlated
-1.30%
SCPH - HLVX
33%
Loosely correlated
-0.24%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-1.30%
VCYT - NTLA
69%
Closely correlated
-1.17%
CRSP - NTLA
66%
Loosely correlated
+1.37%
BEAM - NTLA
64%
Loosely correlated
-0.87%
RXRX - NTLA
57%
Loosely correlated
-7.13%
ABCL - NTLA
55%
Loosely correlated
-2.27%
More